Evidence map›Paper›PMID 16449637›Full record

ArticleMolecular and cellular biology2006

Cyclic AMP inhibits p38 activation via CREB-induced dynein light chain.

Jiyan Zhang, Truc N Bui, Jialing Xiang, Anning Lin

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 64 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Clinical, Genetic and Functional Characterization of a NovelJournal of personalized medicine · 2022
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Unconventional functions of microtubule motors.Archives of biochemistry and biophysics · 2012
    Review
  12. Article
  13. Cyclic AMP: a selective modulator of NF-κB action.Cellular and molecular life sciences : CMLS · 2011
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Jiyan ZhangBen May Institute for Cancer Research, The University of Chicago, 929 East 57th Street, Chicago, IL 60637, USA.
Truc N Bui
Jialing Xiang
Anning Lin
University of Chicago · USIllinois Institute of Technology · USMay Institute · US

Funding

Integration of TNF Signaling in ApoptosisR01CA100460 · NCI · UNIVERSITY OF CHICAGO · PI LIN, ANNING · 2003 to 2010
$2.2M
Regulation of I kappa B Kinase in ApoptosisR01CA092650 · NCI · UNIVERSITY OF CHICAGO · PI LIN, ANNING · 2001 to 2005
$1.3M
NCI NIH HHS CA100460NCI NIH HHS CA92650NCI NIH HHS R01 CA092650NCI NIH HHS R01 CA100460
6 · The paper itself

Abstract

The mitogen-activated protein kinase p38 plays a critical role in inflammation, cell cycle progression, differentiation, and apoptosis. The activity of p38 is stimulated by a variety of extracellular stimuli, such as the proinflammatory cytokine tumor necrosis factor alpha (TNF-alpha), and subjected to regulation by other intracellular signaling pathways, including the cyclic AMP (cAMP) pathway. Yet the underlying mechanism by which cAMP inhibits p38 activation is unknown. Here we show that the induction of dynein light chain (DLC) by cAMP response element-binding protein (CREB) is required for cAMP-mediated inhibition of p38 activation. cAMP inhibits p38 activation via the protein kinase A-CREB pathway. The inhibition is mediated by the CREB target gene Dlc, whose protein product, DLC, interferes with the formation of the MKK3/6-p38 complex, thereby suppressing p38 phosphorylation activation by MKK3/6. The inhibition of p38 activation by cAMP leads to suppression of NF-kappaB activity and promotion of apoptosis in response to TNF-alpha. Thus, our results identify DLC as a novel inhibitor of the p38 pathway and provide a molecular mechanism by which cAMP suppresses p38 activation and promotes apoptosis.

Indexed as

AnimalsApoptosisCarrier ProteinsCell LineCyclic AMPCyclic AMP-Dependent Protein KinasesCyclic AMP Response Element-Binding ProteinDrosophila ProteinsDyneinsEnzyme ActivationHumansMAP Kinase Signaling SystemMiceModels, BiologicalNF-kappa BNIH 3T3 CellsCarrier ProteinsCyclic AMPCyclic AMP-Dependent Protein KinasesCyclic AMP Response Element-Binding ProteinDrosophila ProteinsDyneinsNF-kappa Bp38 Mitogen-Activated Protein KinasesTumor Necrosis Factor-alpha

Identifiers

PMID16449637
PMCPMC1367190
OpenAlexW2130801035

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.